EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.2.23 | Acquired Immunodeficiency Syndrome |
28185054 |
Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy. |
causal interaction |
3 |
| 2.3.2.23 | Acquired Immunodeficiency Syndrome |
28185054 |
Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy. |
diagnostic usage |
1 |
| 2.3.2.23 | Acquired Immunodeficiency Syndrome |
28185054 |
Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy. |
therapeutic application |
4 |
| 2.3.2.23 | Acquired Immunodeficiency Syndrome |
21281599 |
The E2-25K ubiquitin-associated (UBA) domain aids in polyubiquitin chain synthesis and linkage specificity. |
unassigned |
0 |
| 2.3.2.23 | Acquired Immunodeficiency Syndrome |
28185054 |
Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy. |
unassigned |
0 |
| 2.3.2.23 | Adenocarcinoma |
23355337 |
Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis. |
causal interaction |
4 |
| 2.3.2.23 | Adenocarcinoma |
22760214 |
UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. |
causal interaction |
4 |
| 2.3.2.23 | Adenocarcinoma |
24918063 |
Inhibitors of the Cdc34 acidic loop: A computational investigation integrating molecular dynamics, virtual screening and docking approaches. |
causal interaction |
4 |
| 2.3.2.23 | Adenocarcinoma |
28260026 |
UBE2C induces EMT through Wnt/??catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A. |
causal interaction |
4 |
| 2.3.2.23 | Adenocarcinoma |
29662619 |
Uev1A-Ubc13 promotes colorectal cancer metastasis through regulating CXCL1 expression via NF-?B activation. |
causal interaction |
4 |
